Your browser is no longer supported. Please, upgrade your browser.
AGEN Agenus Inc. daily Stock Chart
Agenus Inc.
Index- P/E- EPS (ttm)-1.40 Insider Own17.78% Shs Outstand121.06M Perf Week11.55%
Market Cap444.29M Forward P/E- EPS next Y-1.44 Insider Trans0.00% Shs Float98.65M Perf Month80.79%
Income-147.20M PEG- EPS next Q-0.28 Inst Own32.10% Short Float10.16% Perf Quarter78.16%
Sales38.70M P/S11.48 EPS this Y15.90% Inst Trans-0.01% Short Ratio5.27 Perf Half Y63.84%
Book/sh-1.13 P/B- EPS next Y-6.70% ROA-110.70% Target Price7.00 Perf Year-5.90%
Cash/sh- P/C- EPS next 5Y- ROE136.20% 52W Range1.54 - 6.19 Perf YTD54.20%
Dividend- P/FCF- EPS past 5Y-19.10% ROI-119.00% 52W High-40.71% Beta2.29
Dividend %- Quick Ratio1.20 Sales past 5Y21.90% Gross Margin- 52W Low138.31% ATR0.28
Employees255 Current Ratio1.20 Sales Q/Q276.50% Oper. Margin- RSI (14)71.94 Volatility8.69% 10.98%
OptionableYes Debt/Eq- EPS Q/Q21.90% Profit Margin- Rel Volume1.40 Prev Close3.73
ShortableYes LT Debt/Eq- EarningsFeb 05 BMO Payout- Avg Volume1.90M Price3.67
Recom- SMA2029.75% SMA5048.16% SMA20044.26% Volume2,659,346 Change-1.61%
Oct-28-16Downgrade H.C. Wainwright Buy → Neutral $10 → $5
Oct-27-16Reiterated Maxim Group Buy
Mar-11-16Upgrade Maxim Group Hold → Buy $7
Dec-16-15Initiated Jefferies Buy
Oct-27-15Downgrade Maxim Group Buy → Hold
Jul-27-15Reiterated MLV & Co Buy $9 → $11
Jun-11-15Initiated Oppenheimer Outperform $14
Jan-12-15Reiterated Maxim Group Buy $10 → $11
Jan-09-15Reiterated MLV & Co Buy $6 → $9
Jan-09-15Reiterated Maxim Group Buy $10 → $11
Dec-19-14Reiterated Maxim Group Buy $8 → $10
May-08-14Reiterated Maxim Group Buy $17 → $11
Mar-14-14Reiterated MLV & Co Buy $9 → $11
Oct-08-13Reiterated Maxim Group Buy $19
Jan-05-12Initiated William Blair Outperform
Dec-01-11Initiated Global Hunter Securities Buy $6
Jan-09-19 07:30AM  Research Report Identifies Conagra Brands, W.R. Grace, International Flavors & Fragrances, Spirit Airlines, Sunstone Hotel Investors, and Agenus with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-08-19 08:38AM  Agenus (AGEN) Surges: Stock Moves 9.4% Higher Zacks
Jan-07-19 12:17PM  Why Agenus Stock Is Spiking Today Motley Fool +9.43%
Jan-06-19 10:00AM  All the Pre-JPM News Healthcare Investors Need to Know Motley Fool
Jan-04-19 08:31AM  Are Options Traders Betting on a Big Move in Agenus (AGEN) Stock? Zacks +6.07%
Jan-03-19 04:31PM  Why Celgene, Agenus, and Incyte Jumped Today Motley Fool +11.55%
04:22PM  Here's Why Agenus Shares Rose as Much as 13.5% Today Motley Fool
11:30AM  Agenus Awarded Grant to Enable QS-21 Innovations PR Newswire
Dec-26-18 10:32AM  3 Biotech Stocks That Are Too Cheap to Ignore Motley Fool +12.61%
09:34AM  Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal Zacks
Dec-23-18 09:03AM  2 Beaten-Down Biotech Stocks That Look Like Bargains Now Motley Fool
Dec-21-18 09:19AM  Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead Zacks -8.87%
08:00AM  Major Biotech Deals Making Sector Red Hot ACCESSWIRE
Dec-20-18 12:48PM  Why Agenus Stock Is Soaring Today Motley Fool +23.38%
09:30AM  4 Biotech Stocks Making Moves on Thursday December 20, 2018 ACCESSWIRE
08:28AM  Agenus stock shoots up 60% after announcing drug development deal with Gilead MarketWatch
07:48AM  Gilead, Agenus sign deal to develop immuno-oncology therapies Reuters
07:30AM  Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies PR Newswire
07:30AM  Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies Business Wire
Dec-17-18 07:00AM  Today's Research Reports on Trending Tickers: Amarin Corporation and Agenus ACCESSWIRE -8.68%
Dec-06-18 09:30AM  Why Is Agenus (AGEN) Up 11.6% Since Last Earnings Report? Zacks
Dec-05-18 10:18PM  Here's Why Agenus Stock Popped 51.6% in November Motley Fool
Dec-04-18 12:00PM  Orchestra BioMed Appoints C. Evan Ballantyne as Chief Financial Officer GlobeNewswire -6.85%
Nov-19-18 05:00AM  Edited Transcript of AGEN earnings conference call or presentation 6-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
Nov-13-18 04:05PM  Agenus Elects New Board Member Dr. Allison Jeynes-Ellis and Appoints Chief Operating Officer Dr. Jennifer Buell PR Newswire
11:30AM  Agenus to Present at the 2018 Jefferies London Healthcare Conference PR Newswire
Nov-09-18 07:55AM  Report: Developing Opportunities within Agenus, Kirkland's, Preferred Apartment Communities, Gulfport Energy, ProAssurance, and US Ecology Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-08-18 04:28PM  Agenus (AGEN) Q3 Loss Wider Than Expected, Pipeline in Focus Zacks
Nov-06-18 05:42PM  Agenus to Present Data on Neoantigen Vaccines and anti-CD137 Antibody at SITC 2018 PR Newswire
09:00AM  Agenus (AGEN) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:54AM  Agenus: 3Q Earnings Snapshot Associated Press
07:30AM  Agenus Reports Third Quarter 2018 Financial Results and Provides Corporate Update PR Newswire
Oct-31-18 09:23AM  Agenus to Report Third Quarter 2018 Financial Results on November 6, 2018 and Host Conference Call and Webcast PR Newswire
Oct-30-18 10:33AM  Will Agenus (AGEN) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-20-18 07:30AM  Agenus Presents Clinical Data on Its PD-1 & CTLA-4 at ESMO 2018 PR Newswire
Oct-09-18 09:00AM  Agenus To Present Data on Proprietary CTLA-4 & PD-1 Antibodies at ESMO 2018 PR Newswire
Oct-08-18 08:25AM  Recent Analysis Shows Ryman Hospitality Properties, PennantPark Investment, PS Business Parks, Agenus, Belden, and Robert Half International Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Oct-05-18 08:48AM  Celyad (CYAD) Jumps: Stock Rises 6.8% Zacks
Sep-28-18 08:38AM  Agenus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York, NY PR Newswire
Sep-21-18 07:00AM  Agenus Closes $15 Million Partial Royalty Monetization With XOMA PR Newswire
Sep-19-18 09:27AM  How Does Investing In Agenus Inc (NASDAQ:AGEN) Impact Your Portfolio? Simply Wall St.
Sep-18-18 06:18PM  Agenus Receives Milestone Payment of $5 Million from Incyte Zacks
Sep-17-18 09:00AM  Agenus Receives Milestone Payment from Incyte PR Newswire -7.11%
Sep-14-18 08:57AM  Implied Volatility Surging for Agenus (AGEN) Stock Options Zacks
Sep-07-18 07:32AM  Why Agenus' Stock Perked Up in August Motley Fool
Sep-05-18 07:34PM  AgenTus Therapeutics to Present on the Anti-tumor Activities of Two Proprietary T Cell Receptors (TCRs) at CAR-TCR Summit in Boston, MA PR Newswire
Sep-04-18 09:57AM  Agenus to Present at The Annual B. Riley FBR Healthcare Conference in New York City PR Newswire
Aug-31-18 04:30AM  Agenus (AGEN) Continue to Surge Higher? Zacks +5.24%
Aug-27-18 09:55AM  Edited Transcript of AGEN earnings conference call or presentation 9-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-23-18 10:00AM  Is Agenus Inc. Stock a Buy? Motley Fool
Aug-17-18 07:39AM featured highlights include: Dollar Tree, Agenus, Huntsman, ArcelorMittal and International Paper Zacks
Aug-16-18 08:42AM  Step Beyond Bargain Hunting & Tap Rising P/E With 5 Stocks Zacks
Aug-15-18 01:22PM  Agenus Receives Second Milestone Payment from Merck PR Newswire -5.59%
09:56AM  Agenus (AGEN) Delivering Well on Its Pipeline Candidates Zacks
Aug-10-18 09:32AM  Agenus' (AGEN) Q2 Loss Narrower Than Expected, Revenues Beat Zacks
Aug-09-18 10:55AM  Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates Zacks
09:52AM  Agenus: 2Q Earnings Snapshot Associated Press
09:42AM  Agenus (AGEN) Reports Narrower than Expected Loss in Q2 Zacks
08:00AM  Agenus Reports Second Quarter 2018 Financial Results and Provides Corporate Update PR Newswire
06:30AM  Agenus Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 02:00PM  Agenus to Report Second Quarter 2018 Financial Results on August 9, 2018 and Host Conference Call and Webcast PR Newswire
Jul-30-18 03:55PM  Will Agenus (AGEN) Disappoint Investors This Earnings Season? Zacks +5.08%
Jul-27-18 07:45AM  New Research: Key Drivers of Growth for Cadence Design, Agenus, Foundation Medicine, Honeywell International, NeoPhotonics, and Citrix Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jul-21-18 08:25AM  Should Biotech Investors Fear Dilution? Motley Fool
Jul-17-18 08:37AM  Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4 Benzinga
Jul-16-18 08:37AM  Agenus Appoints Regulatory and Clinical Heads PR Newswire -5.02%
Jun-20-18 08:00AM  Agenus to Webcast Annual Meeting of Stockholders PR Newswire +9.49%
Jun-18-18 06:30AM  National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up CNW Group
Jun-12-18 08:30AM  Agenus Discovery Enhances Activity of Cancer Fighting Antibodies; Findings Published in Cancer Cell PR Newswire
Jun-11-18 07:40AM  Todays Free Research Reports Coverage on Agenus and Three More Biotech Stocks ACCESSWIRE -6.13%
Jun-06-18 01:00PM  Agenus to Present at the Jefferies 2018 Global Healthcare Conference in New York, NY PR Newswire
08:17AM  Agenus (AGEN) Down 1.5% Since Earnings Report: Can It Rebound? Zacks
Jun-04-18 01:35PM  Agenus Presents Clinical Responses of AGEN1884 (anti-CTLA-4) and AGEN2034 (anti-PD-1) at ASCO 2018 PR Newswire
Jun-03-18 07:27PM  The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines Benzinga
May-17-18 01:37PM  Agenus to Present Clinical Data on Lead Programs at ASCO 2018 PR Newswire
May-12-18 09:28AM  Is Agenus Inc. (AGEN) a Buy? Motley Fool
May-09-18 11:46PM  Edited Transcript of AGEN earnings conference call or presentation 7-May-18 3:00pm GMT Thomson Reuters StreetEvents +7.91%
07:48AM  Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway Benzinga
May-08-18 03:59PM  Agenus' (AGEN) Q1 Loss Wider than Expected, Shares Down Zacks
May-07-18 01:00PM  Agenus to Present at Deutsche Bank's 43rd Annual Health Care Conference in Boston PR Newswire -9.78%
09:13AM  Agenus: 1Q Earnings Snapshot Associated Press
09:00AM  Agenus Reports First Quarter 2018 Financial Results and Provides Corporate Update PR Newswire
08:15AM  Agenus Inc. to Host Earnings Call ACCESSWIRE
May-05-18 09:16AM  2 Beaten-Down Biotech Stocks That Look Like Bargains Now Motley Fool
May-03-18 09:00AM  Agenus to Report First Quarter 2018 Financial Results on May 7, 2018 and Host Conference Call and Webcast PR Newswire
May-01-18 08:00AM  AgenTus Therapeutics to Present on Novel TCR Platform and Progress at PEGS Summit in Boston, MA PR Newswire
Apr-30-18 10:57AM  Will Agenus (AGEN) Disappoint Investors This Earnings Season? Zacks
Apr-16-18 03:20AM  Why Is Agenus (AGEN) Down 17.7% Since its Last Earnings Report? Zacks -11.61%
Apr-11-18 04:07PM  Will Agenus Incs (NASDAQ:AGEN) Earnings Grow Over The Next Few Years? Simply Wall St.
10:00AM  Three Agenus Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) 2018 Annual Meeting PR Newswire
Mar-29-18 08:30AM  Agenus to Present at Healthcare Investor Conferences In April PR Newswire
Mar-16-18 10:31AM  Agenus (AGEN) Q4 Loss Wider Than Expected, Revenues Miss Zacks +5.61%
02:34AM  Edited Transcript of AGEN earnings conference call or presentation 15-Mar-18 3:00pm GMT Thomson Reuters StreetEvents
Mar-15-18 10:09AM  Agenus (AGEN) Reports Wider than Expected Q4 Loss, Sales Miss Zacks
08:45AM  Agenus reports 4Q loss Associated Press
08:30AM  Agenus Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update PR Newswire
07:45AM  Agenus Inc. to Host Earnings Call ACCESSWIRE
Mar-07-18 10:19AM  Steven Cohen Takes Stake in Biotech Company Agenus
08:00AM  Agenus to Report Fourth Quarter and Full Year 2017 Financial Results on March 15, 2018 and Host Conference Call and Webcast PR Newswire
Mar-06-18 01:31PM  Has Agenus Inc (NASDAQ:AGEN) Improved Earnings Growth In Recent Times? Simply Wall St.
Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. The company offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized monoclonal antibodies; SECANT yeast display, an antibody discovery platform used for the generation of novel monoclonal antibodies; and phage display technologies. It is also developing checkpoint modulating antibody candidates targeting GITR, OX40, TIM-3, LAG-3, and others. In addition, the company develops vaccine programs, including Prophage cancer vaccine candidate; AutoSynVax, a synthetic neo-antigen; and PhosPhoSynVax, a vaccine candidate designed to induce immunity against a class of tumor specific neo-epitopes. Further, it develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. Additionally, the company engages in the development of CTLA-4 and PD-1 antagonists; and anti-CTLA-4, CD137, and anti-TIGIT antibodies, as well as various multi-specific antibodies that are under various stages of development. Agenus Inc. has collaboration agreements with Incyte Corporation, Merck Sharpe & Dohme, and Recepta Biopharma SA.; and collaboration with Gilead Sciences, Inc. to develop immuno-oncology therapies. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.